Inventor

MAZANETZ MICHAEL PHILIP

GB7 patents

⚠️ This page may combine multiple inventors who share the name “MAZANETZ MICHAEL PHILIP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LILLY CO ELI

2 patents

US8022062B2Sep 20, 2011

6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists

LILLY CO ELI4 citations59

US7981882B2Jul 19, 2011

6-N-linked heterocycle-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists

LILLY CO ELI0 citations38

HOFFMANN MATTHIAS

1 patent

US8969568B2Mar 3, 2015

Substituted naphthyridines and their use as medicaments

HOFFMANN MATTHIAS2 citations60

BOEHRINGER INGELHEIM INT

1 patent

US9187478B2Nov 17, 2015

Substituted naphthyridines and their use as medicaments

BOEHRINGER INGELHEIM INT0 citations50

BRINER KAREN

1 patent

US8680091B2Mar 25, 2014

6-arylalkylamino-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists

BRINER KAREN1 citations38

ALLEN JOHN GORDON

1 patent

US8420631B2Apr 16, 2013

6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists

ALLEN JOHN GORDON0 citations30

BADESCU VALENTINA O

1 patent

US8202873B2Jun 19, 2012

2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists

BADESCU VALENTINA O0 citations30